BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 21220711)

  • 1. Nanoparticle-mediated delivery of pitavastatin into lungs ameliorates the development and induces regression of monocrotaline-induced pulmonary artery hypertension.
    Chen L; Nakano K; Kimura S; Matoba T; Iwata E; Miyagawa M; Tsujimoto H; Nagaoka K; Kishimoto J; Sunagawa K; Egashira K
    Hypertension; 2011 Feb; 57(2):343-50. PubMed ID: 21220711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanoparticle-Mediated Targeting of Pitavastatin to Small Pulmonary Arteries and Leukocytes by Intravenous Administration Attenuates the Progression of Monocrotaline-Induced Established Pulmonary Arterial Hypertension in Rats.
    Ichimura K; Matoba T; Koga JI; Nakano K; Funamoto D; Tsutsui H; Egashira K
    Int Heart J; 2018 Nov; 59(6):1432-1444. PubMed ID: 30369578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanoparticle-mediated delivery of nuclear factor kappaB decoy into lungs ameliorates monocrotaline-induced pulmonary arterial hypertension.
    Kimura S; Egashira K; Chen L; Nakano K; Iwata E; Miyagawa M; Tsujimoto H; Hara K; Morishita R; Sueishi K; Tominaga R; Sunagawa K
    Hypertension; 2009 May; 53(5):877-83. PubMed ID: 19307469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amlodipine prevents monocrotaline-induced pulmonary arterial hypertension and prolongs survival in rats independent of blood pressure lowering.
    Mawatari E; Hongo M; Sakai A; Terasawa F; Takahashi M; Yazaki Y; Kinoshita O; Ikeda U
    Clin Exp Pharmacol Physiol; 2007 Jul; 34(7):594-600. PubMed ID: 17581214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attenuation of monocrotaline-induced pulmonary arterial hypertension in rats by rosuvastatin.
    Li XL; Guan RJ; Li JJ
    J Cardiovasc Pharmacol; 2012 Aug; 60(2):219-26. PubMed ID: 22592772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delivery of imatinib-incorporated nanoparticles into lungs suppresses the development of monocrotaline-induced pulmonary arterial hypertension.
    Akagi S; Nakamura K; Miura D; Saito Y; Matsubara H; Ogawa A; Matoba T; Egashira K; Ito H
    Int Heart J; 2015 May; 56(3):354-9. PubMed ID: 25902888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intratracheal Administration of Prostacyclin Analogue-incorporated Nanoparticles Ameliorates the Development of Monocrotaline and Sugen-Hypoxia-induced Pulmonary Arterial Hypertension.
    Akagi S; Nakamura K; Matsubara H; Kondo M; Miura D; Matoba T; Egashira K; Ito H
    J Cardiovasc Pharmacol; 2016 Apr; 67(4):290-8. PubMed ID: 26745002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nebivolol for improving endothelial dysfunction, pulmonary vascular remodeling, and right heart function in pulmonary hypertension.
    Perros F; Ranchoux B; Izikki M; Bentebbal S; Happé C; Antigny F; Jourdon P; Dorfmüller P; Lecerf F; Fadel E; Simonneau G; Humbert M; Bogaard HJ; Eddahibi S
    J Am Coll Cardiol; 2015 Feb; 65(7):668-80. PubMed ID: 25677428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ruscogenin exerts beneficial effects on monocrotaline-induced pulmonary hypertension by inhibiting NF-κB expression.
    Zhu R; Bi L; Kong H; Xie W; Hong Y; Wang H
    Int J Clin Exp Pathol; 2015; 8(10):12169-76. PubMed ID: 26722401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum-glucocorticoid regulated kinase 1 regulates macrophage recruitment and activation contributing to monocrotaline-induced pulmonary arterial hypertension.
    Xi X; Liu S; Shi H; Yang M; Qi Y; Wang J; Du J
    Cardiovasc Toxicol; 2014 Dec; 14(4):368-78. PubMed ID: 24825325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydrogen ameliorates pulmonary hypertension in rats by anti-inflammatory and antioxidant effects.
    Kishimoto Y; Kato T; Ito M; Azuma Y; Fukasawa Y; Ohno K; Kojima S
    J Thorac Cardiovasc Surg; 2015 Sep; 150(3):645-54.e3. PubMed ID: 26095621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eicosapentaenoic acid ameliorates pulmonary hypertension via inhibition of tyrosine kinase Fyn.
    Kurahara LH; Hiraishi K; Yamamura A; Zhang Y; Abe K; Yahiro E; Aoki M; Koga K; Yokomise H; Go T; Ishikawa K; Bo Z; Kishi H; Kobayashi S; Aoki-Shoi N; Toru S; Inoue R; Hirano K
    J Mol Cell Cardiol; 2020 Nov; 148():50-62. PubMed ID: 32889002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Betaine Attenuates Monocrotaline-Induced Pulmonary Arterial Hypertension in Rats via Inhibiting Inflammatory Response.
    Yang JM; Zhou R; Zhang M; Tan HR; Yu JQ
    Molecules; 2018 May; 23(6):. PubMed ID: 29861433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanoparticle-mediated endothelial cell-selective delivery of pitavastatin induces functional collateral arteries (therapeutic arteriogenesis) in a rabbit model of chronic hind limb ischemia.
    Oda S; Nagahama R; Nakano K; Matoba T; Kubo M; Sunagawa K; Tominaga R; Egashira K
    J Vasc Surg; 2010 Aug; 52(2):412-20. PubMed ID: 20573471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Salvianolic acid A attenuates vascular remodeling in a pulmonary arterial hypertension rat model.
    Chen YC; Yuan TY; Zhang HF; Wang DS; Yan Y; Niu ZR; Lin YH; Fang LH; Du GH
    Acta Pharmacol Sin; 2016 Jun; 37(6):772-82. PubMed ID: 27180980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bortezomib alleviates experimental pulmonary arterial hypertension.
    Kim SY; Lee JH; Huh JW; Kim HJ; Park MK; Ro JY; Oh YM; Lee SD; Lee YS
    Am J Respir Cell Mol Biol; 2012 Nov; 47(5):698-708. PubMed ID: 22842494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluoxetine protects against monocrotaline-induced pulmonary arterial remodeling by inhibition of hypoxia-inducible factor-1α and vascular endothelial growth factor.
    Han DD; Wang Y; Zhang XH; Liu JR; Wang HL
    Can J Physiol Pharmacol; 2012 Apr; 90(4):445-54. PubMed ID: 22448962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Additive effect of tadalafil and simvastatin on monocrotaline-induced pulmonary hypertension rats.
    Zhang WH; Liu CP; Zhang YJ; Ji YQ; Lu WX; Zeng Q
    Scand Cardiovasc J; 2012 Dec; 46(6):374-80. PubMed ID: 22971207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic efficacy of AAV1.SERCA2a in monocrotaline-induced pulmonary arterial hypertension.
    Hadri L; Kratlian RG; Benard L; Maron BA; Dorfmüller P; Ladage D; Guignabert C; Ishikawa K; Aguero J; Ibanez B; Turnbull IC; Kohlbrenner E; Liang L; Zsebo K; Humbert M; Hulot JS; Kawase Y; Hajjar RJ; Leopold JA
    Circulation; 2013 Jul; 128(5):512-23. PubMed ID: 23804254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calorie Restriction Attenuates Monocrotaline-induced Pulmonary Arterial Hypertension in Rats.
    Ding M; Lei J; Qu Y; Zhang H; Xin W; Ma F; Liu S; Li Z; Jin F; Fu E
    J Cardiovasc Pharmacol; 2015 Jun; 65(6):562-70. PubMed ID: 25636073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.